Tel Aviv - Delayed Quote ILA

Evogene Ltd. (EVGN.TA)

550.60

-20.40

(-3.57%)

At close: January 30 at 5:24:48 PM GMT+2

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities

Despite a dip in quarterly revenue, Evogene Ltd (EVGN) advances with strategic collaborations and promising future prospects.

GuruFocus.com 2 months ago

EVGN.TA
-3.57%
Evogene: Q3 Earnings Snapshot

REHOVOT, Israel (AP) — Evogene Ltd. (EVGN) on Thursday reported a loss of $7.6 million in its third quarter. The Rehovot, Israel-based company said it had a loss of $1.31 per share. The agricultural company posted revenue of $1.8 million in the period.

Associated Press Finance 2 months ago

EVGN.TA
-3.57%
Evogene Reports Third Quarter 2024 Financial Results

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene" or the "Company"), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the third quarter period ended September 30, 2024.

PR Newswire 2 months ago

EVGN
-1.27%
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced significant progress in the development of its LAV321 bio-fungicide, targeting downy mildew. Over three years of field trials across Europe, evaluating the efficacy of LAV321 in protecting crops from fungal diseases, LAV321 demonstrated an impressive average efficacy rate of 70% against downy mildew in grapes. These results lead to the decision to advance it to the last st

PR Newswire 2 months ago

EVGN
-1.27%
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced the commercial expansion of Yalos® seed-treatment to soybean, following successful field trials performed in 2024 in the US. Yalos®, Lavie Bio's first commercial bio-inoculant product available in the US and Canada, demonstrated yield increase by more than 5% on average, in soybean.

PR Newswire 2 months ago

EVGN
-1.27%
Evogene Schedules Third Quarter 2024 Financial Results Release

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the third quarter of 2024, on Thursday, November 21, 2024.

PR Newswire 2 months ago

EVGN
-1.27%
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, today announced a collaboration with Google Cloud to develop a cutting-edge foundation model for generative small molecule de novo design, propelling Evogene's ChemPass AI tech-engine to new levels of innovation. ChemPass AI is a computational technology platform that directs and accelerates the discovery and development of novel products

PR Newswire 2 months ago

EVGN
-1.27%
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company for oil production for bio-based products and biofuel, and a subsidiary of Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), today announced a key milestone in its operational expansion plan in Africa with the delivery of its first shipment of over 100 tons of castor seeds to its customer in Africa, seeds that were cultivated at several sites in Kenya and processed in a seed production facility near Naivasha, Ke

PR Newswire 3 months ago

EVGN
-1.27%
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology

Watershed AC ("Watershed", formerly Colors Farm Ltd.), a cutting-edge company in sustainable aquaculture and biotech and Evogene Ltd. ("Evogene") (NASDAQ: EVGN)(TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, together with Ben-Gurion University (BGU), a renowned Israeli academic research institution, announced receiving an approval from IIA for a second year grant to continue developing CRISPR technology for crust

PR Newswire 3 months ago

EVGN
-1.27%
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), announced receiving a grant from the Israel Innovation Authority (IIA) to advance its program to develop a breakthrough technology for the delivery of ag-biologicals to agriculture. This patented technology, named 'MicroFermentor', is based on an innovative microbe formulation that enables the multiplication of beneficial bacteria directly on the plant, reducing application costs, exten

PR Newswire 3 months ago

EVGN
-1.27%
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement

Evogene Ltd. ("Evogene" or the "Company") (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development utilizing cutting-edge computational biology technologies across multiple market segments, announced today that it has entered into definitive agreements with a single health-care focused institutional investor for the purchase and sale of 1,692,308 ordinary shares (or ordinary share equivalents in lieu thereof)

PR Newswire 5 months ago

EVGN
-1.27%
Evogene: Q2 Earnings Snapshot

REHOVOT, Israel (AP) — Evogene Ltd. (EVGN) on Thursday reported a loss of $5.4 million in its second quarter. The Rehovot, Israel-based company said it had a loss of $1.06 per share. The agricultural company posted revenue of $914,000 in the period.

Associated Press Finance 5 months ago

EVGN.TA
-3.57%
Evogene Reports Second Quarter 2024 Financial Results

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the second quarter period ended June 30, 2024.

PR Newswire 5 months ago

EVGN
-1.27%
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Listing Rule 5550(a)(2), which requires the Company's ordinary shares to maintain a minimum bid price of $1.00 per share.

PR Newswire 5 months ago

EVGN
-1.27%
Evogene Schedules Second Quarter 2024 Financial Results Release

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the second quarter of 2024, on Thursday, August 22, 2024.

PR Newswire 5 months ago

EVGN
-1.27%
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil

Casterra Ag Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), and a provider of an integrated solution for industrial-scale cultivation of castor, based on its elite castor seed varieties, developed for bio-based industries including biopolymers & biofuels, is pleased to announce the successful completion of its current castor growing and harvesting season in Brazil. The seeds are planned to be shipped during the third quarter of this year. In addition, the castor harvesting season

PR Newswire 5 months ago

EVGN
-1.27%
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company" or "Evogene"), a leading computational biology company targeting to revolutionize life-science-based product discovery and development utilizing cutting edge computational biology technologies, across multiple market segments, announced today that a reverse share split of its issued and outstanding Ordinary Shares, at a ratio of 1-for-10, is expected to be implemented after market close on July 24, 2024. The Company's Ordinary Shares will b

PR Newswire 6 months ago

EVGN
-1.27%
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced a significant milestone in their collaboration to develop bio-stimulant solutions for key row crops facing various abiotic stresses. By leveraging artificial intelligence (AI), Lavie Bio has computationally identified more than a dozen novel microbial candidates believed to have commercial viabil

PR Newswire 6 months ago

EVGN
-1.27%
ICL
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat

Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), is pleased to announce the commercial expansion of its bio-inoculant product, Yalos™, to winter wheat, following successful trials. This expansion effectively doubles the potential market for Yalos™ compared to markets in which Lavie Bio already operates. Winter wheat growers across the US will have access to Yalos™ for the upcoming 2024-2025 season.

PR Newswire 6 months ago

EVGN
-1.27%
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country

Casterra Ag Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), is a provider of an integrated solution for industrial-scale cultivation of castor plants based on its elite castor seed varieties, developed for bio-based industries including, biofuels & biopolymers. Casterra is pleased to announce the receipt of an additional purchase order valued at ~$440K from an existing customer. This order expands Casterra's operations into a new African country and solidifies Casterra's unique o

PR Newswire 7 months ago

EVGN
-1.27%

Performance Overview

Return	EVGN.TA	TA-125
YTD	-15.20%	+4.50%
1-Year	-80.19%	+32.37%
3-Year	-86.89%	+23.74%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Evogene Ltd. (EVGN.TA)

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities

Evogene: Q3 Earnings Snapshot

Evogene Reports Third Quarter 2024 Financial Results

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Evogene Schedules Third Quarter 2024 Financial Results Release

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement

Evogene: Q2 Earnings Snapshot

Evogene Reports Second Quarter 2024 Financial Results

Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Evogene Schedules Second Quarter 2024 Financial Results Release

Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil

Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split

ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants

Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat

Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country

Performance Overview